From: Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
 | Genes | Roles | Targets or pathways | Cancer cell types | Refs |
---|---|---|---|---|---|
Cargo sorting | hnRNPA2B1 | Oncogene | miR-122-5p, circNEIL3 | NSCLC, glioma | |
hnRNPK | Oncogene | miR-148a-3p | Prostate cancer | [45] | |
hnRNPH1 | Oncogene | - | Prostate cancer | [152] | |
hnRNPA1 | Oncogene | lncRNA ELNAT1 | Bladder cancer | [85] | |
MVP | Oncogene | miR-193a | Colon cancer | [83] | |
Hsp90 | Oncogene | Rab22a-NeoF1 | Osteosarcoma | [75] | |
ILV formation | Hrs | Oncogene | ESCRT dependent | HNSCC, breast cancer | [128] |
HD-PTP | Suppressor | ESCRT dependent | HeLa cell | ||
Vps4A | Suppressor | ESCRT dependent | HCC | [32] | |
SRC | Oncogene | Syndecan-Syntenin-Alix | CML, breast cancer | [147] | |
Heparanase | Oncogene | Syndecan-Syntenin-Alix | Glioma | [148] | |
Ral | Oncogene | Syndecan-Syntenin-Alix | Breast cancer | [146] | |
TSPN6 | Suppressor | Syntenin dependent | CRC | [149] | |
Caveolin-1 | Oncogene | ESCRT independent | Prostate and breast cancer | ||
Rab31/ Flotillins | Oncogene | ESCRT independent | NCI-H1975, MDA-MB231, and HeLa cells | [50] | |
Rab35 | Oncogene | ESCRT independent | HCC | [135] | |
MVB transport and fusion | Rab27a/b | Oncogene | Docking | HNSCC, HCC, cervical, ovarian, breast, Melanoma, bladder and lung cancer | |
Rab17 | Oncogene | - | NSCLC | [120] | |
Rab7 | Oncogene | Syndecan-Syntenin-Alix, ER-endosome contact sites | Breast cancer | ||
Cortactin | Oncogene | F-actin reorganization | NSCLC, breast cancer | ||
Syt7 | Oncogene | MVB-plasma membrane Fusion | NSCLC, breast cancer | ||
Munc13–4 | Oncogene | MVB maturation | Breast cancer | [98] | |
Exocyst | Oncogenes | MVB-PM Fusion | HNSCC | [119] |